period of 2017, the profit was Baht 3.67 million, a decline of 3,689.37%. The Company would like to clarify significant changes in the Group’s operating results are as follows: 1. Revenues from sales and

period of 2017, the profit was Baht 3.67 million, a decline of 3,689.37%. The Company would like to clarify significant changes in the Group’s operating results as follows: 1. Revenues from sales and

has decreased by 6.30% despite total hospital income from general patients increased 8.69% compared with the same period of last year. This is mainly due to the medical-service-fee adjustment caused by

margin in Q2/2024 was 66.5%, increased from 64.2% in Q2/2023, and Gross Profit margin in 1H/2024 was 66.5%, increased from 64.1% in 1H/2023, mainly due to the increase in sales revenue and the Company’s

margin in Q3/2021 was 52.2%, decreased from 62.6% in Q3/2020 and gross profit margin in 9M/2021 was 56.1%, decreased from 60.6% in 9M/2021. • The decrease was mainly due to the temporary closure of all

1 Ref: CIG 037/2017 August 15, 2017 Subject: Profit and loss reporting for the second quarter of 2017 and explanation of more than 20 percent fluctuation in profit and loss compared to that of last

19.82%. Revenue decreased from revenue from Sales Baht 703.18 million, decreased by 26.56%, from sales in material product group due to fluctuations in global markets from US and EU policies. Used

Baht or 21.63% due to banking fees. Net profit (loss) The company recorded net loss of 5.37 million Baht in the second quarter of 2018, a decrease of 10.06 million Baht compared with net loss of 15.43

24.41%. Revenue decreased from revenue from Sales Baht 529.49 million, decreased by 31.92%, from sales in material product group due to fluctuations in global markets from US and EU policies. Used

Company Limited and Subsidiaries hereafter refer as (The Company) would like to clarify the Company’s operating results for the year ended December 31, 2018. The Company had the net profit of 10.03 million